Publications by authors named "Yuxin Mu"

Claim this Profile
A
A Phase I open-label study to assess the pharmacokinetics, safety, and tolerability of capivasertib alone or in combination with paclitaxel in Chinese patients with advanced solid tumors.
Jian Zhang, Xiaojun Liu, Yiqun Du, Yuxin Mu, Yanchun Meng

BMC Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel 4-sulfur-substituted pyrazol-5-yl-benzamide derivatives containing amide/hydrazide/ester moieties as potential succinate dehydrogenase inhibitors.
Yantao Li, Yuxin Mu, Jun Xiong, Dan Xu, Xili Liu

Pest Manag Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of inetetamab-containing regimens in patients with HER2-positive metastatic breast cancer in first-line/second-line setting.
Jian Zhang, Yuxin Mu, Hui Zhang, Chao Deng, Jiao Yang

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RRP9-JUN axis promotes breast cancer progression via the AKT signalling pathway.
Jinliang Huan, Xiaojun Liu, Na Wang, Yuxin Mu, Ling Li

Biol Direct· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Evaluation of Novel 1-Methyl-1-pyrazol-5-amine Derivatives with Disulfide Moieties as Potential Antimicrobial Agents.
Yantao Li, Yuxin Mu, Yuan Cao, Dan Xu, Xili Liu

J Agric Food Chem· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors.
Jian Zhang, Yiqun Du, Yanchun Meng, Xiaojun Liu, Yuxin Mu

NPJ Precis Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study.
Jian Zhang, Yiqun Du, Yanchun Meng, Xiaojun Liu, Yuxin Mu

Chin Clin Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Lactiplantibacillus plantarum on oxidative stress, mitophagy, and NLRP3 inflammasome activation in broiler breast meat.
Junmeng Yuan, Fan Zhao, Yu Liu, Huawei Liu, Kai Zhang, Yuxin Mu

Poult Sci· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer.
Yuxin Mu, Yanchun Meng, Yiqun Du, Xiaojun Liu, Jian Zhang

Thorac Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors.
Jiani Wang, Lin Gui, Yuxin Mu, Jiayu Wang, Yihebali Chi

BMC Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Proteomics Analysis Reveals Attenuated Endoplasmic Reticulum Stress in -Treated Oxidatively Stressed Broilers.
Junmeng Yuan, Yu Liu, Fan Zhao, Yuxin Mu, Xinyu Tian

J Agric Food Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease monitoring of epidermal growth factor receptor (EGFR)-mutated non-small-cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor DNA.
Yan Li, Ziyi Xu, Shouzheng Wang, Yixiang Zhu, Di Ma, Yuxin Mu

Thorac Cancer· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification of electrocardiogram signals with waveform morphological analysis and support vector machines.
Hongqiang Li, Zhixuan An, Shasha Zuo, Wei Zhu, Lu Cao, Yuxin Mu

Med Biol Eng Comput· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer.
Jiani Wang, Qingyuan Zhang, Qiao Li, Yuxin Mu, Jing Jing

Target Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence-Enabled ECG Algorithm Based on Improved Residual Network for Wearable ECG.
Hongqiang Li, Zhixuan An, Shasha Zuo, Wei Zhu, Zhen Zhang, Yuxin Mu

Sensors (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical significance of RET gene fusion among Chinese patients with lung cancer.
Puyuan Xing, Nong Yang, Xue Hu, Yuxin Mu, Shouzheng Wang

Transl Cancer Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acquired resistance to osimertinib in patients with non-small-cell lung cancer: mechanisms and clinical outcomes.
Yuxin Mu, Xuezhi Hao, Puyuan Xing, Xingsheng Hu, Yan Wang

J Cancer Res Clin Oncol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nab-paclitaxel in combination with Bevacizumab in patients with non-squamous non-small cell lung cancer after failure of at least one prior systemic regimen.
Xuezhi Hao, Yixiang Zhu, Yuxin Mu, Shouzheng Wang, Junling Li

J Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dense paclitaxel plus carboplatin . epirubicin and cyclophosphamide with paclitaxel as adjuvant chemotherapy for high-risk triple-negative breast cancer.
Qing Li, Jiani Wang, Yuxin Mu, Tongtong Zhang, Ying Han

Chin J Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics and Treatment Outcomes of 65 Patients With BRAF-Mutated Non-small Cell Lung Cancer.
Yuxin Mu, Ke Yang, Xuezhi Hao, Yan Wang, Lin Wang

Front Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data Of Osimertinib In Patients With Pretreated Non-Small Cell Lung Cancer: A Retrospective Study.
Yuxin Mu, Puyuan Xing, Xuezhi Hao, Yan Wang, Junling Li

Cancer Manag Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world data on EGFR/ALK gene status and first-line targeted therapy rate in newly diagnosed advanced non-small cell lung cancer patients in Northern China: A prospective observational study.
Hongge Liang, Xia Song, Yuhui Zhang, Shucai Zhang, Fang Li, Yuxin Mu

Thorac Cancer· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of afatinib in a Chinese population with advanced lung adenocarcinoma with sensitive EGFR mutations.
Shouzheng Wang, Puyuan Xing, Ke Yang, Xuezhi Hao, Di Ma, Yuxin Mu

Thorac Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Modality of Resistance and Subsequent Management of Patients with Advanced Non-small Cell Lung Cancer Failing Treatment with Osimertinib.
Yuxin Mu, Xuezhi Hao, Ke Yang, Di Ma, Shouzheng Wang

Target Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real world study of the continuation of bevacizumab beyond disease progression after first-line treatment containing bevacizumab in Chinese patients with advanced non-small cell lung cancer.
Puyuan Xing, Yuxin Mu, Yan Wang, Xuezhi Hao, Yixiang Zhu

Thorac Cancer· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis